Preliminary evidence for leukocyte transcriptional signatures for pediatric ventilator-associated pneumonia

Jason A Werner1, William Schierding, David Dixon

  • 1The Department of Pediatrics, St. Louis University School of Medicine, St. Louis, MO 63110, USA. jwerner2@slu.edu

Insights

Blood RNA expression profiles show promise for tracking ventilator-associated pneumonia (VAP) in children. These preliminary findings suggest a detectable VAP signal in gene expression, warranting further investigation.

Area of Science:

  • Pediatric critical care medicine
  • Molecular diagnostics
  • Genomics

Background:

  • Ventilator-associated pneumonia (VAP) is a major cause of morbidity and mortality in pediatric intensive care units (ICUs).
  • Diagnosing VAP in children presents significant challenges.
  • Previous studies in adults suggested blood RNA expression profiles could aid in VAP detection.

Purpose of the Study:

  • To investigate the potential of blood RNA expression profiles for monitoring VAP response in children.
  • To determine if gene expression patterns can differentiate between ventilated children with and without VAP.

Main Methods:

  • A pilot, nonrandomized, repeated measures case-control study.
  • Analysis of blood RNA abundance in buffy coat samples from 7 mechanically ventilated children (1-18 months old).
  • Gene expression profiling using Affymetrix Human Genome Focus GeneChip and statistical analysis (ANOVA).

Main Results:

  • Expression patterns of 48 genes differentiated between children with and without VAP.
  • Gene expression network analysis identified pathways related to cell proliferation, differentiation, growth, and apoptosis.
  • Several novel genes implicated in sepsis were identified.

Conclusions:

  • Preliminary data support the hypothesis that a detectable VAP signal exists in blood gene expression profiles of critically ill children.
  • These findings are the first to demonstrate this in a pediatric population.
  • Larger studies are needed to validate these results and assess the diagnostic utility of longitudinal RNA signatures.
Abstract

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...